Psoriatic arthritis combines painful joint inflammation with skin symptoms, creating unique challenges ... more precise therapies in the future. Clinical trials exploring combination therapies ...

Psoriatic arthritis (PsA) is a chronic (long-lasting) condition that combines the skin-related symptoms of psoriasis with the joint-related symptoms of arthritis. PsA is an autoimmune disease ...

Among patients with PsA, MetS is associated with certain degenerative changes in the spine and entheses but not with peripheral or axial radiographic damage.

This autoimmune disorder manifests through various symptoms that can significantly ... those genetically susceptible. The clinical presentation of psoriatic arthritis varies dramatically across ...

In a study of more than 600 psoriatic arthritis (PsA ... lab results, radiographic features, disease characteristics, comorbidities, and patient-reported outcomes. The goal of this analysis ...

The results confirm a suspicion long held by the authors: that early symptoms of psoriatic ... national clinical lead for the National Early Inflammatory Arthritis Audit (NEIAA) at the British ...

The FDA has approved a label extension for Johnson & Johnson’s Tremfya (guselkumab) in psoriatic arthritis ... on results from two pivotal phase 3 clinical trials, DISCOVER-1 and DISCOVER ...

Patients with psoriatic arthritis (PsA) experienced longer diagnostic ... and matched to an equal number of patients with RA. Clinical data on 28 tender and swollen joint counts, patient global ...